(Q28235143)

English

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

scientific article (publication date: April 2011)

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Acceptable changes in quality attributes of glycosylated biopharmaceuticals (English)

0 references

1 reference

Martin Schiestl

1

0 references

Thomas Stangler

series ordinal

2

0 references

Claudia Torella

series ordinal

3

0 references

Tadej Cepeljnik

series ordinal

4

0 references

Hansjörg Toll

series ordinal

5

0 references

Roger Grau

series ordinal

6

0 references

language of work or name

English

0 references

publication date

April 2011

0 references

published in

Nature Biotechnology

0 references

volume

29

0 references

issue

4

0 references

page(s)

310-2

0 references

cites work

Characterizing biological products and assessing comparability following manufacturing changes.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Development and characterization of novel erythropoiesis stimulating protein (NESP)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Mechanisms of killing by anti-CD20 monoclonal antibodies.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Understanding and circumventing resistance to anticancer monoclonal antibodies.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT.1839

retrieved

21 January 2018

Determination of the origin of the N-terminal pyro-glutamate variation in monoclonal antibodies using model peptides

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21478841

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q28235143)

Acceptable changes in quality attributes of glycosylated biopharmaceuticals

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)